Abstract: The present invention provides methods for selecting a suitable anticancer drug for the treatment of patient with non-small cell lung cancer (NSCLC). The present invention also provides methods for determining drug resistance in NSCLC patients receiving EGFR inhibitor therapy.
Type:
Application
Filed:
July 29, 2015
Publication date:
February 4, 2016
Applicant:
NESEC S.A,
Inventors:
Sharat Singh, Phillip Kim, Steven Lockton